The John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, New Orleans, LA, USA.
Ochsner Clinical School, Faculty of Medicine, The University of Queensland, New Orleans, LA, USA.
BMC Res Notes. 2020 Sep 17;13(1):439. doi: 10.1186/s13104-020-05272-2.
Patients with end-stage heart failure (ESHF) treated with ventricular assist devices (VADs) tend to gain weight after implantation, which is associated with higher complication rates and is a contraindication for heart transplantation (HT). The objective was to analyze the outcomes of obese patients with ESHF and VADs who underwent laparoscopic sleeve gastrectomy (LSG) at Ochsner Medical Center in New Orleans, which is the only program performing VADs and HT in the State of Louisiana, and also one of the largest VAD centers in the USA.
This dataset contains detailed baseline, perioperative, and long-term data of patients with VADs undergoing LSG. These variables were collected retrospectively from electronic medical records. Patients who achieved ≥ 50% excess BMI loss, BMI ≤ 35 kg/m, listing for HT, HT, or myocardial recovery were identified and the timing to each of these milestones was documented. These data can be used alone or in combination with other datasets to achieve a larger sample size with more power for further analysis of these variables, which include the most important, standard, and objective bariatric and ESHF outcomes of patients with VADs undergoing LSG. Elaboration of composite outcomes is feasible.
接受心室辅助装置 (VAD) 治疗的终末期心力衰竭 (ESHF) 患者在植入后往往会体重增加，这与更高的并发症发生率有关，并且是心脏移植 (HT) 的禁忌症。目的是分析在新奥尔良奥克斯纳医疗中心接受腹腔镜袖状胃切除术 (LSG) 的肥胖 ESHF 和 VAD 患者的结局，该中心是路易斯安那州唯一一家同时开展 VAD 和 HT 的项目，也是美国最大的 VAD 中心之一。
该数据集包含接受 LSG 的 VAD 患者的详细基线、围手术期和长期数据。这些变量是从电子病历中回顾性收集的。确定了达到≥50%超重指数 (BMI) 损失、BMI≤35kg/m、HT 适应证、HT 或心肌恢复的 VAD 患者，并记录了达到这些里程碑的时间。这些数据可以单独使用或与其他数据集结合使用，以获得更大的样本量和更大的分析这些变量的能力，这些变量包括接受 LSG 的 VAD 患者最重要、标准和客观的减肥和 ESHF 结局。复合结局的详细说明是可行的。
